SCHEMBL7350550

SCHEMBL7350550

O=c1[nH]c(Cc2ccnnc2)nc2c[nH]nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.40
▸ ADORA3 P0DMS8 2/20 0.38
▸ GAA P10253 1/20 0.33
▸ HCAR2 Q8TDS4 1/20 0.33
▸ DAO P14920 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ PDE5A O76074 1/20 0.32
▸ PDE9A O76083 1/20 0.32
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ PNP P00491 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ RNASEH1 O60930 2/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ ACVR1 Q04771 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7348346 0.74 PNP (0.47) KMT2AADORA3DAOPDE9APNP
SCHEMBL22118823 0.72 KDM4E (0.42) KMT2AADORA3MAPTPKM
SCHEMBL7379913 0.72 TNKS2 (0.50) ADORA3GAAMAPTKDM4CACVR1
SCHEMBL7420122 0.68 CACNA1H (0.37) ADORA3GAAHCAR2MAPTPKM
SCHEMBL14281548 0.67 PARP1 (0.46) ADORA3GAAMAPT
SCHEMBL10796662 0.66 — —
SCHEMBL7422513 0.66 ADORA3 (0.33) ADORA3GAAPDE9APDE1APDE1B
SCHEMBL22119325 0.65 CYP1A2 (0.32) —
SCHEMBL22118927 0.65 ADORA3 (0.33) KMT2AADORA3GAAPKM
SCHEMBL22119321 0.64 PNP (0.40) PNPRNASEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977756-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2000-02-09 — — EP disclosed
WO-1998049166-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 1998-11-05 — — WO disclosed
Send feedback